BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8908082)

  • 1. Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy.
    Antoine C; Garnier JL; Duboust A; Bariéty J; Stevenson G; Glotz D
    Transplant Proc; 1996 Oct; 28(5):2825-6. PubMed ID: 8908082
    [No Abstract]   [Full Text] [Related]  

  • 2. Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation.
    Goldfarb JM; Larson ML; Venugopal P; Gregory SA
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):600-4; discussion 604-6. PubMed ID: 17099618
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody.
    Bernard F; Sarran N; Margueritte G; Barneon G; Astruc J
    Med Pediatr Oncol; 2001 Feb; 36(2):329-31. PubMed ID: 11452947
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD20 antibodies to treat lymphoproliferative syndromes following renal transplantation.
    Abderrahim E; Karoui C; Smaoui W; Raies L; Ben Abdallah T; Hedri H; Ben Moussa F; Bardi R; Ayed K; Maïz HB
    Transplant Proc; 2003 Nov; 35(7):2708-9. PubMed ID: 14612084
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT.
    Kawaguchi T; Tsukamoto S; Ohwada C; Takeuchi M; Muto T; Tanaka S; Sakai S; Takeda Y; Abe D; Sakaida E; Shimizu N; Yokote K; Iseki T; Imadome KI; Nakaseko C
    Bone Marrow Transplant; 2011 Dec; 46(12):1583-5. PubMed ID: 21278799
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic disorders in posttransplant lymphoma: therapeutic implications.
    Jacobs U; Niese D; Brensing KA; Eis-Hübinger A; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3249-50. PubMed ID: 8962259
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of post-transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograft.
    Molnar I; Keung YK
    Nephrol Dial Transplant; 2001 Oct; 16(10):2114-5. PubMed ID: 11572917
    [No Abstract]   [Full Text] [Related]  

  • 8. Multifocal primary colonic lymphoma in a patient with posttransplantation lymphoproliferative disease: CT findings.
    Horton KM; Fishman EK
    AJR Am J Roentgenol; 1998 Jun; 170(6):1672. PubMed ID: 9609203
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
    Fischer A; Blanche S; Le Bidois J; Bordigoni P; Garnier JL; Niaudet P; Morinet F; Le Deist F; Fischer AM; Griscelli C
    N Engl J Med; 1991 May; 324(21):1451-6. PubMed ID: 2023604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
    Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
    Porter DL; Orloff GJ; Antin JH
    Transplant Sci; 1994 Sep; 4(1):12-4; discussion 14-6. PubMed ID: 7804691
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation.
    Kataoka K; Seo S; Ota S; Takahashi T; Kurokawa M
    Bone Marrow Transplant; 2010 Mar; 45(3):610-2. PubMed ID: 19684636
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr Virus-negative posttransplant lymphoproliferative disorder with coexisting native renal cell carcinoma: PET/CT demonstration.
    Nguyen BD; Ram PC; Roarke MC
    Clin Nucl Med; 2006 Apr; 31(4):218-20. PubMed ID: 16550020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy.
    Castagnola E; Dallorso S; Faraci M; Morreale G; Di Martino D; Cristina E; Scarso L; Lanino E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):9-10. PubMed ID: 12662431
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus-associated lymphoproliferative disorder presenting as apparently isolated gastrointestinal lesions in childhood.
    Sebire NJ; Malone M; Risdon RA; Ramsay AD
    Pediatr Dev Pathol; 2005; 8(1):88-91. PubMed ID: 15717118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder?
    Cockfield SM; Preiksaitis J; Harvey E; Jones C; Hebert D; Keown P; Halloran PF
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1106-7. PubMed ID: 1846454
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
    Friend PJ; Rebello P; Oliveira D; Manna V; Cobbold SP; Hale G; Jamieson NV; Jamieson I; Calne RY; Harris DT
    Transplant Proc; 1995 Feb; 27(1):869-70. PubMed ID: 7879212
    [No Abstract]   [Full Text] [Related]  

  • 19. CT findings in posttransplantation lymphoproliferative disorder of renal transplants.
    Vrachliotis TG; Vaswani KK; Davies EA; Elkahammas EA; Bennett WF; Bova JG
    AJR Am J Roentgenol; 2000 Jul; 175(1):183-8. PubMed ID: 10882272
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr-virus-associated lymphoproliferative disease of the lung: CT and histologic findings.
    Collins J; Müller NL; Leung AN; McGuinness G; Mergo PJ; Flint JD; Warner TF; Poirier C; Theodore J; Zander D; Yee HT
    Radiology; 1998 Sep; 208(3):749-59. PubMed ID: 9722856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.